OPTimizing Treatment Focused Genetic Testing IN Cancer

Clinical trial NCT04066361 · COMPLETED

Trial details

NCT number: NCT04066361
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Pancreatic Cancer Prostate Cancer

Start date: 2019-12-19
Primary completion: 2022-11-30
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.